Real-world drug outcomes

Clinical trials have guidelines, called eligibility criteria, about who can participate. The criteria ensure that only a selected set of people are participated. When the drugs are released in the market, the findings of the selected participants are generalized to the much bigger public. It is thus not uncommon for drugs to behave differently in the real world than in clinical trials.

The 21st Century Cures Act, passed in 2016, places additional focus on the use of real-world data to support regulatory decision making. The FDA has started to use real-world data to monitor postmarket safety and adverse events, and payers to support value-based payment program.

eHealthMe has been monitoring drugs and supplements since 2008. Our real-world drug studies have been referenced on 600+ peer-reviewed medical publications. On eHealthMe, you can manage drugs with real-world experiences from a pool of 16 million and counting patients.